(HealthDay News) -- Here are the latest clinical trials,
This study will evaluate the safety and effectiveness of an
investigational drug in reducing the risk of atrial fibrillation.
Participants will receive study drug, study-related lab tests and
medical exams at no cost, and may qualify for time and travel
The research site is in Kenosha, Wisc.
This study will evaluate an investigational topical gel for
redness associated with rosacea. To qualify, you must be 18 or
older and be in good general health.
The research site is in New York City.
Post Herpetic Neuralgia (PHN)
This study is evaluating an investigational topical drug for
post herpetic neuralgia pain. If you qualify, you will receive
study-related exams and investigational drug, and may be
compensated for time and travel expenses.
The research site is in Albuquerque, N.M.
ClinicalConnection.com. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.